NTT Precision Medicine and Integrity Healthcare Announces Capital Alliance

2024/12/23
プレスリリース
 
　NTT Precision Medicine, Corp. (Headquarters: Chiyoda-ku, Tokyo, President and CEO: Koji Korekawa, hereinafter referred to as "NTT Precision Medicine") and Integrity Healthcare, Co., Ltd. (Headquarters: Chuo-ku, Tokyo, Chairman: Shinsuke Muto, President and CEO: Ai Sonoda, hereinafter referred to as "Integrity Healthcare") are pleased to announce that they have entered into a capital alliance. NTT Precision Medicine, a new company that was launched in July 2024 by bringing together the assets and resources related to the NTT Group's medical and healthcare businesses, intends to make Integrity Healthcare an equity-method affiliate as the first capital alliance since its establishment. Through close capital and business collaboration, the two companies aim to achieve continuous business growth and social contribution in the medical and healthcare fields in Japan.
 
 
 
１．Overview of the two companies
Company Name: NTT Precision Medicine Co., Ltd.
 
Business Content:
  • Provision of related services that promote the digitalization of medical institutions
  • Provision of medical and healthcare services through the use of data such as medical information
  • Provision of genetic testing services
Group Companies:
  • Prime Research Institute for Medical RWD, Inc. (PRiME-R, Inc.)
  • Clinical Support, Corp.
Strengths and Responsibilities:
  • Implementation of Genovision® services at more than 50 health checkup institutions nationwide
  • Possession of genetic testing information and chronological health checkup member data of approximately 90,000 people
  • Possession of the Japan Precision-medicine Platform, which collects various medical and healthcare data such as clinical data, laboratory data, and genetic data from medical institutions and research institutes in Japan in an integrated manner, and allows researchers and pharmaceutical companies from around the world to use the data securely and smoothly.
  • Implementation of Cyber Oncology® at more than 40 medical institutions nationwide, including university hospitals

 

Company name: Integrity Healthcare Co., Ltd.
 
Business Content: Creation of a new medical model utilizing digital technology
  • Digital Platform Business
  • Well-being Business
  • DCT*1 Business (Group company: DCT Japan)
Strengths and Responsibilities:
  • Provision of a digital platform at more than 6,000 medical institutions nationwide
  • Proven track record of doing business with more than 25 pharmaceutical companies (11 of the world's top 15 pharmaceutical companies)
  • A Well-being business that supports health and productivity management centered on "Smart One Health,” an in-house medical clinic service that utilizes PHR*2 and online medical examinations
  • With over 200 registered nurses in Japan, the DCT business has a strong track record of numerous transactions with overseas pharmaceutical companies and CROs*3 through nationwide service deployment
 
 
２．Collaboration Themes
  • Building a Medical Data Platform
    Improvement of additional value for medical institutions and establishment of an EHR*4/PHR data infrastructure by linking the cloud-based electronic medical record developed and deployed by NTT Precision Medicine with the PHR system and online medical examination system developed and deployed by Integrity Healthcare
  • Well-being Business
    Joint development of health management support services for companies and health insurance associations utilizing data and technology, and promotion of joint businesses including sales and marketing
  • DCT Business
    Collaboration with NTT Precision Medicine Group's services to build DCT solutions and promote business in Japan and overseas
* Genovision Dock® is a registered trademark of NTT Precision Medicine, Corp.
* CyberOncology® is a registered trademark of the Prime Research Institute for Medical RWD, Inc.
* Smart One Health is a registered trademark of Integrity Healthcare Co., Ltd.
 
References and Annotations
*1 DCT: Decentralized Clinical Trial
*2 PHR: Personal Health Record
*3 CRO: Contract Research Organization
*4 EHR: Electronic Health Record
 
 
【Inquiries regarding this announcement】
Integrity Healthcare Co., Ltd. Public Relations Officer: Hibi
E-mail：pr@integrity-healthcare.co.jp
 
NTT Precision Medicine Co., Ltd. Business Promotion Department representatives: Motoyama, Shintaku, Nakayama
E-mail：nttlsc-ba-ml@ntt.com
 
 
End of document

関連記事